Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cerivastatin

Drug Profile

Cerivastatin

Alternative Names: BAY W 6228; Baycol; Certa; Cervasta; Cholstat; Lipobay; Liposterol; Micro®; Rivastatin; Selta; Staltor; Stativa™; Vaslip; Zenas Micro

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer
  • Developer Bayer; Chiesi; Ferrer; Fournier Pharma; Fournier Pharma Inc; GlaxoSmithKline; Laboratorios Vita
  • Class Antihyperlipidaemics; Pyridines
  • Mechanism of Action HMG-CoA reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Market Withdrawal Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia; Low HDL cholesterol

Most Recent Events

  • 24 Apr 2003 Groupe Fournier is now called Fournier Pharma
  • 23 Aug 2001 Withdrawn for Hypercholesterolaemia in Japan (PO)
  • 09 Aug 2001 Bayer has withdrawn cerivastatin worldwide except in Japan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top